United Kingdom

People: Allergan plc (AGN.N)

AGN.N on New York Stock Exchange

23 Aug 2019
Change (% chg)

$-1.97 (-1.22%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Freyman, Thomas 

Mr. Thomas C. Freyman is Director of the Company. Mr. Freyman retired from Abbott Laboratories (“Abbott”) in 2017. Most recently, he served as Executive Vice President, Finance and Administration for Abbott since June 2015. Prior to that, he served as Chief Financial Officer and Executive Vice President, Finance for Abbott. He was first appointed Chief Financial Officer and Senior Vice President, Finance at Abbott in 2001. Previously, he served as Vice President and Controller of Abbott’s Hospital Products Division and held a number of financial planning and analysis positions. Prior to joining Abbott, Mr. Freyman was a certified public accountant at Ernst & Whinney. Mr. Freyman holds a bachelor’s degree in accounting from the University of Illinois and a master’s degree in management from Northwestern University. He also serves on the Board of Directors of Tenneco Inc. and Hanger, Inc., serving on the audit committee of each of those boards.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --